Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
about
A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophyVascular endothelial dysfunction and pharmacological treatmentFlow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophinSystemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptorsANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development.Angiotensin II attenuates renal cortical cyclooxygenase-2 expression.Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes.Angiotensin AT2 receptors: cardiovascular hope or hype?Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats.Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietinLocal fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic herniaRegulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage.Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin.A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH.Angiotensin II type-2 receptor-specific effects on the cardiovascular system.Adapter proteins and promoter regulation of the angiotensin AT2 receptor--implications for cardiac pathophysiology.Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.The angiotensin II type 2 receptor in cardiovascular disease.SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension.Salt, Angiotensin II, Superoxide, and Endothelial Function.Therapeutic targets of renin-angiotensin system in ocular disorders.Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis.Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells.AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation.Angiotensin II AT(2) receptor inhibits smooth muscle cell migration via fibronectin cell production and binding.Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR.The involvement of AT(2)-receptor in the antithrombotic effect of losartan in renal hypertensive rats.Maternal High-Fat Diet Causes a Sex-Dependent Increase in AGTR2 Expression and Cardiac Dysfunction in Adult Male Rat Offspring.Changing dietary sodium alters the chronic cardiovascular effects of losartan in rats.Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice.Blood pressure, arterial stiffness and endogenous lithium clearance in relation to AGTR1 A1166C and AGTR2 G1675A gene polymorphisms.Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension.
P2860
Q24634320-230F671A-00CA-468C-8D7A-00ED78EA5201Q26774561-268C1258-618B-4509-A193-3B93AB99234AQ28348557-72EFBAFD-F5AE-483A-BDB9-97742343072FQ28364369-C7A2931C-040B-40DF-831D-CA62C7B041E3Q30434317-359E45AA-CF2B-4936-86B5-376EAF55AE12Q33848631-C62048A1-68C1-43AF-B4F9-D96983DD6259Q34075171-EFFD9E2C-34FD-4BB5-B8E1-A487D193FF42Q35045801-D9D531FA-D022-4C07-9C86-1BC289FA2A4EQ35085406-6BD112DF-5E2C-436E-AED0-96592F6DE7E4Q35791973-1477A7BD-F27D-46A2-A995-87F4ADD582B9Q35872512-AE627E82-23D6-47AC-B9C0-F35FB0BD7547Q36067015-299AA0D2-650E-4AB8-BC64-C784AF95E7CEQ36100744-AB657EBB-AFEC-4E4A-8EF1-A335E6B203CEQ36241932-69C51BFC-377A-4FDD-AFC6-DF8064F4FF15Q36893345-AD469B70-4959-4374-BC2B-9135B23069F6Q36894216-37E07C03-B866-4A5F-B5CE-67A9330A2AB7Q37269304-690A6E10-D38E-4A9A-804E-E99B67A22C54Q37339329-E3309D97-0ABE-4847-871B-88B4C1B92573Q37598488-CA1EB94B-B447-43A8-8C66-A5909CEE7377Q37600856-A71E7C33-8FAF-4756-A592-A63BE647581BQ37600876-A7B5F72B-3659-4EAE-BED2-753D45F931A9Q37622575-912600B1-C093-4D42-91BD-A5AC27EC0FE2Q38346586-72DA4E3D-5BAF-42D6-8301-B6579863CD29Q38693277-EB16F91C-14A7-4068-AB56-C164258DF85CQ39214578-6A7FFD30-C2EB-4451-9571-AA58949C13C5Q39737596-FB8BE740-62F9-46A3-91AA-EAAD8936CDC2Q39973660-7A69C763-7D5C-448D-838B-F45A61C3996BQ41819451-A6803AE3-7FF8-44C8-9767-8E6BB687006CQ42518248-CCA0AC0F-50DC-4917-B575-852859DBDE38Q42987208-5EB83382-3201-47AD-B21A-9FB087C5E235Q43106907-834EEE7A-752C-4539-A959-26C11508F395Q43640230-4988189F-B09E-4EC0-9508-32105BD24567Q43907226-89E0E6E5-4FA4-4554-8A7B-E9E0475F21B2Q44356539-2C517D37-9352-49C7-9595-391D0B3AD261Q44851212-8F7F4218-74E6-4A2D-A86E-2ED6F5495CEAQ47752119-8FEA0F21-3DF9-4300-B23B-FD6BBB19B3F0Q51684297-A1CB47F2-099E-431F-A884-80F35B1FEC39Q52170561-6478DED8-765E-40FE-B46E-BDB7F30C08A7
P2860
Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic blockade of AT2-subtyp ...... on the rat vascular structure.
@en
Chronic blockade of AT2-subtyp ...... on the rat vascular structure.
@nl
type
label
Chronic blockade of AT2-subtyp ...... on the rat vascular structure.
@en
Chronic blockade of AT2-subtyp ...... on the rat vascular structure.
@nl
prefLabel
Chronic blockade of AT2-subtyp ...... on the rat vascular structure.
@en
Chronic blockade of AT2-subtyp ...... on the rat vascular structure.
@nl
P2093
P2860
P356
P1476
Chronic blockade of AT2-subtyp ...... on the rat vascular structure
@en
P2093
Benessiano J
Poitevin P
P2860
P304
P356
10.1172/JCI118807
P407
P577
1996-07-01T00:00:00Z